Elevance Health Inc.ELVNYSE
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank44
3Y CAGR+3.9%
5Y CAGR+74.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+3.9%/yr
vs -13.0%/yr prior
5Y CAGR
+74.2%/yr
Recent deceleration
Acceleration
+17.0pp
Accelerating
Percentile
P44
Within normal range
vs 5Y Ago
16x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.67% |
| Q3 2025 | 0.53% |
| Q2 2025 | 3.16% |
| Q1 2025 | 3.37% |
| Q4 2024 | -3.29% |
| Q3 2024 | 3.37% |
| Q2 2024 | 4.12% |
| Q1 2024 | 3.48% |
| Q4 2023 | 3.22% |
| Q3 2023 | 1.15% |
| Q2 2023 | 2.66% |
| Q1 2023 | 3.31% |
| Q4 2022 | 1.49% |
| Q3 2022 | 0.95% |
| Q2 2022 | -0.17% |
| Q1 2022 | -0.12% |
| Q4 2021 | 1.57% |
| Q3 2021 | 2.64% |
| Q2 2021 | 3.54% |
| Q1 2021 | 2.33% |
| Q4 2020 | 0.10% |
| Q3 2020 | -1.08% |
| Q2 2020 | 8.80% |
| Q1 2020 | 0.10% |
| Q4 2019 | 2.18% |
| Q3 2019 | 2.35% |
| Q2 2019 | 2.81% |
| Q1 2019 | 5.21% |
| Q4 2018 | -1.08% |
| Q3 2018 | 0.97% |
| Q2 2018 | 5.15% |
| Q1 2018 | 2.04% |
| Q4 2017 | 2.66% |
| Q3 2017 | 0.92% |
| Q2 2017 | 1.23% |
| Q1 2017 | 3.69% |
| Q4 2016 | 1.23% |
| Q3 2016 | 2.03% |
| Q2 2016 | 2.85% |
| Q1 2016 | 1.56% |